BICLUSTER_ID : UPREG-140
PATHOGENS /2/ : brucella melitensis,ehrlichia chaffeensis
TARGETS /25/ : BCL2, PLAT, CD44, CCL2, ATP5D, NDUFB8, TNFRSF1B, HCK, NDUFB5, TGFB1, CD86, MPO, NDUFA8, GZMB, LTB, NDUFAB1, IL6, SERPINE1, IL1B, SDHD, NDUFS3, ICAM1, TNF, PLAUR, NDUFC1
Gene SetLeading Edge Genes
NETPATH IL 2 PATHWAY UPBCL2, TNFRSF1B, NMI, SOCS3, TRAFD1, CCL4, GZMB, PAX4, IER3, IFIT1, IL12RB1, CSF1, LTB, S100A4, RALB, TRIM21, SRC, LCP2, IL6, GYPA, IL1B, SERPINE1, CCL3, DAXX, ICAM1, CTSC, MYC, PLAUR, TNF, GZMA
MOOTHA VOXPHOSATP5I, ATP5C1, UQCR, ATP5D, NDUFB8, COX5B, NDUFB5, CYC1, NDUFA8, ATP5O, COX4I1, UQCRB, ATP5J, COX7A2, COX6A1, NDUFAB1, COX7C, UQCRC2, COX6C, SDHD, NDUFS3, NDUFC1
NCI AMB2 NEUTROPHILS PATHWAYPLAT, TLN1, HCK, SRC, IL6, ICAM1, MPO, TNF, PLAUR
NETPATH IL 5 PATHWAY UPPLSCR1, BIRC3, NFKB2, BCL2, CCL2, CD44, LTB, IL1A, LCP2, IL1B, CCL3, ICAM1, CTSC, CD24, PRDM1, IER3
NETPATH IL 1 PATHWAY UPBIRC3, CCL2, IL1A, PRG1, CCL7, NFKBIA, CHI3L1, IL6, SERPINE1, IL1B, MT2A, ICAM1, CXCL2, MYC, CCL4
NETPATH IL 3 PATHWAY UPCCL2, SOCS3, CCL7, CCL3, IL1B, TGFB1, CD86, MYC, TNF, CCL4
NCI IL23PATHWAYSOCS3, NFKBIA, IL1B, CCL2, MPO, TNF
SA MMP CYTOKINE CONNECTIONIL1B, TGFB1, TNFRSF1B, TNF
NETPATH IL 4 PATHWAY DOWNPDGFB, GADD45B, CCL2, LTB, GBP2, NFKBIA, GEM, ICAM1, CXCL2, TNF, GZMA
NETPATH IL 7 PATHWAY UPFAS, CCL3, BCL2, CD44, CD86, CXCL2, MYC, CCL4
NETPATH IL 9 PATHWAY UPCCL2, JUNB, SOCS3, CCL7, CCL3, MYC, GZMA, GZMB
ST TUMOR NECROSIS FACTOR PATHWAYNFKBIA, NFKBIB, BIRC3, NFKB2, TNFRSF1B, TNF
NETPATH IL 6 PATHWAY UPSOCS3, GADD45B, CEBPD, JUNB, PRDM1, TNF
BIOCARTA IL10 PATHWAY
BIOCARTA PML PATHWAY
GRAHAM CML DIVIDING VS NORMAL QUIESCENT UP
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
MONTERO THYROID CANCER POOR SURVIVAL UP
BIOCARTA NFKB PATHWAY
WEINMANN ADAPTATION TO HYPOXIA DN
KEGG GRAFT VERSUS HOST DISEASE
REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
ZHU CMV 24 HR UP
NCI TNFPATHWAY
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
RADAEVA RESPONSE TO IFNA1 UP
AMIT EGF RESPONSE 40 HELA
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
MISHRA CARCINOMA ASSOCIATED FIBROBLAST UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
WU HBX TARGETS 3 UP
BIOCARTA LAIR PATHWAY
LE EGR2 TARGETS UP
HINATA NFKB TARGETS KERATINOCYTE UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
VART KSHV INFECTION ANGIOGENIC MARKERS UP
BIOCARTA LYM PATHWAY
DUTTA APOPTOSIS VIA NFKB
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
PAL PRMT5 TARGETS DN
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
MCMURRAY TP53 HRAS COOPERATION RESPONSE UP
REACTOME PROSTANOID HORMONES
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
BIOCARTA ERYTH PATHWAY
REACTOME APOPTOSIS
WINTER HYPOXIA METAGENE
MCLACHLAN DENTAL CARIES UP
IIZUKA LIVER CANCER PROGRESSION G1 G2 UP
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX CHUK KPNA3 NFKB2 NFKBIB REL IKBKG NFKB1 NFKBIE RELB NFKBIA RELA TNIP2
BEGUM TARGETS OF PAX3 FOXO1 FUSION DN
CORUM CHROMOSOMAL PASSENGER COMPLEX CPC INCENP CDCA8 BIRC5 AURKB
LEE LIVER CANCER E2F1 UP
FOSTER INFLAMMATORY RESPONSE LPS DN
LIANG HEMATOPOIESIS STEM CELL NUMBER LARGE VS TINY UP
GAURNIER PSMD4 TARGETS
GRANDVAUX IFN RESPONSE NOT VIA IRF3
NETPATH TNF ALPHA PATHWAY UP
ZHOU INFLAMMATORY RESPONSE LPS UP
GESERICK TERT TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
BERENJENO TRANSFORMED BY RHOA UP
LEE LIVER CANCER MYC E2F1 UP
REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
SESTO RESPONSE TO UV C3
VERHAAK AML WITH NPM1 MUTATED UP
REACTOME DEATH RECEPTOR SIGNALLING
LY AGING MIDDLE DN
GEISS RESPONSE TO DSRNA UP
NCI ANTHRAXPATHWAY
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
CORUM LCK-SLP76-PLC-GAMMA-1-LAT COMPLEX PERVANADATE-ACTIVATED
ZHOU INFLAMMATORY RESPONSE FIMA UP
ROSTY CERVICAL CANCER PROLIFERATION CLUSTER
REACTOME GPCR LIGAND BINDING
TIAN TNF SIGNALING VIA NFKB
GAL LEUKEMIC STEM CELL DN
HUMMEL BURKITTS LYMPHOMA DN
ZHU CMV ALL UP
KEGG SYSTEMIC LUPUS ERYTHEMATOSUS
OKUMURA INFLAMMATORY RESPONSE LPS
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
KEGG TYPE I DIABETES MELLITUS
BENPORATH PROLIFERATION
AMIT EGF RESPONSE 60 MCF10A
HINATA NFKB TARGETS FIBROBLAST UP
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
MISSIAGLIA REGULATED BY METHYLATION UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
WHITEFORD PEDIATRIC CANCER MARKERS
RHODES UNDIFFERENTIATED CANCER
CORUM CHROMOSOMAL PASSENGER COMPLEX CPC CDCA8 AURKB BIRC5
KEGG ASTHMA
AUJLA IL22 AND IL17A SIGNALING
CROONQUIST STROMAL STIMULATION UP
LEE LIVER CANCER MYC TGFA UP
WU CELL MIGRATION
KHETCHOUMIAN TRIM24 TARGETS UP
NCI CMYB PATHWAY
TSAI RESPONSE TO RADIATION THERAPY
BIOCARTA SODD PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
BUDHU LIVER CANCER METASTASIS DN
NETPATH KIT RECEPTOR PATHWAY UP
HARRIS HYPOXIA
DER IFN BETA RESPONSE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLACK UP
SEIKE LUNG CANCER POOR SURVIVAL
RAY TARGETS OF P210 BCR ABL FUSION DN
BASSO CD40 SIGNALING UP
KEGG OLFACTORY TRANSDUCTION
SOUCEK MYC TARGETS
MARZEC IL2 SIGNALING UP
NAGASHIMA NRG1 SIGNALING UP
BIOCARTA BLYMPHOCYTE PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
BILBAN B CLL LPL DN
MAHADEVAN RESPONSE TO MP470 UP
GOLDRATH ANTIGEN RESPONSE
BIOCARTA TID PATHWAY
BILD HRAS ONCOGENIC SIGNATURE
AMUNDSON GAMMA RADIATION RESISTANCE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
KEGG VIRAL MYOCARDITIS
CHIN BREAST CANCER COPY NUMBER UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
KEGG LEISHMANIA INFECTION
DER IFN ALPHA RESPONSE UP
WU HBX TARGETS 1 UP
AMIT EGF RESPONSE 60 HELA
MARKS HDAC TARGETS DN
CHEN HOXA5 TARGETS 9HR UP
DAZARD UV RESPONSE CLUSTER G2
NCI CD40 PATHWAY
MCLACHLAN DENTAL CARIES DN
LEI MYB TARGETS
KEGG ALLOGRAFT REJECTION
LEE LIVER CANCER SURVIVAL DN
AMIT SERUM RESPONSE 40 MCF10A
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
BIOCARTA HSP27 PATHWAY
BIERIE INFLAMMATORY RESPONSE TGFB1
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
MOSERLE IFNA RESPONSE
FONTAINE FOLLICULAR THYROID ADENOMA DN
SENESE HDAC1 AND HDAC2 TARGETS UP
FOSTER INFLAMMATORY RESPONSE LPS UP
REACTOME PECAM1 INTERACTIONS
EBAUER TARGETS OF PAX3 FOXO1 FUSION UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
KIM WT1 TARGETS UP
PEPPER CHRONIC LYMPHOCYTIC LEUKEMIA UP
FERREIRA EWINGS SARCOMA UNSTABLE VS STABLE UP
KEGG CYTOSOLIC DNA SENSING PATHWAY
CHIANG LIVER CANCER SUBCLASS PROLIFERATION UP
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
BIOCARTA KERATINOCYTE PATHWAY
BIOCARTA GRANULOCYTES PATHWAY
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
NETPATH T CELL RECEPTOR PATHWAY UP
CROONQUIST NRAS VS STROMAL STIMULATION DN
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
GOUYER TATI TARGETS UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
MATSUDA NATURAL KILLER DIFFERENTIATION
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
ehrlichia chaffeensis arkansaehrlichia chaffeensis wakullabrucella melitensisGeneSet Name
0.00029 0.00006 0.03203NETPATH_IL_2_PATHWAY_UP
0.00000 0.00000 0.02188MOOTHA_VOXPHOS
0.00021 0.00002 0.02212NCI_AMB2_NEUTROPHILS_PATHWAY
0.00007 0.00000 0.01177NETPATH_IL_5_PATHWAY_UP
0.00744 0.00022 0.00061NETPATH_IL_1_PATHWAY_UP
0.00000 0.00000 0.00052NETPATH_IL_3_PATHWAY_UP
0.00000 0.00020 0.03782NCI_IL23PATHWAY
0.00037 0.00000 0.04554SA_MMP_CYTOKINE_CONNECTION
0.00001 0.00000 0.00471NETPATH_IL_4_PATHWAY_DOWN
0.00034 0.00004 0.02550NETPATH_IL_7_PATHWAY_UP
0.00097 0.00000 0.00000NETPATH_IL_9_PATHWAY_UP
0.00584 0.00254 0.00659ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.00003 0.00000 0.00163NETPATH_IL_6_PATHWAY_UP
0.00082 0.00114 0.15511BIOCARTA_IL10_PATHWAY
0.01308 0.00285 0.13810BIOCARTA_PML_PATHWAY
0.01356 0.01105 0.03032GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.00021 0.00547 0.03113GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.09228 0.00614 0.05509MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
0.06659 0.00699 0.00822BIOCARTA_NFKB_PATHWAY
0.01089 0.04046 0.03080WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.00000 0.00000 0.00487KEGG_GRAFT_VERSUS_HOST_DISEASE
0.00034 0.00004 0.07382REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.00000 0.00000 0.03772ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.05826 0.06209 0.11933ZHU_CMV_24_HR_UP
0.16521 0.06530 0.11377NCI_TNFPATHWAY
0.00094 0.00014 0.03016REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.00007 0.00000 0.01411LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.17481 0.01394 0.01663BIOCARTA_IL1R_PATHWAY
0.00307 0.00001 0.03255RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00000 0.00000 0.00644LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.00000 0.00000 0.09499RADAEVA_RESPONSE_TO_IFNA1_UP
0.03874 0.00042 0.03181AMIT_EGF_RESPONSE_40_HELA
0.00254 0.00166 0.18600BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.00076 0.00056 0.16708MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.01384 0.00174 0.00944THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.01450 0.08662 0.18900WU_HBX_TARGETS_3_UP
0.00046 0.00063 0.01980BIOCARTA_LAIR_PATHWAY
0.00024 0.00000 0.06710LE_EGR2_TARGETS_UP
0.00055 0.00001 0.05127HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.00013 0.00000 0.03717KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.02454 0.01577 0.05150VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.00036 0.00068 0.10226BIOCARTA_LYM_PATHWAY
0.00000 0.00000 0.00246DUTTA_APOPTOSIS_VIA_NFKB
0.11433 0.00777 0.03253COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.01020 0.00109 0.05920PAL_PRMT5_TARGETS_DN
0.00000 0.00000 0.00015DIRMEIER_LMP1_RESPONSE_EARLY
0.00007 0.00650 0.02211DER_IFN_GAMMA_RESPONSE_UP
0.00024 0.00017 0.09016MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.01761 0.01391 0.09761REACTOME_PROSTANOID_HORMONES
0.00000 0.00000 0.02236REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00001 0.00000 0.04288SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.00000 0.00000 0.19040BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.01092 0.00039 0.00487ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.02809 0.00507 0.00670ONDER_CDH1_TARGETS_3_DN
0.07913 0.03887 0.03221BIOCARTA_ERYTH_PATHWAY
0.05149 0.18155 0.13673REACTOME_APOPTOSIS
0.11984 0.01067 0.07019WINTER_HYPOXIA_METAGENE
0.00000 0.00000 0.01108MCLACHLAN_DENTAL_CARIES_UP
0.05216 0.04964 0.18605IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.13511 0.03294 0.06656CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_CHUK_KPNA3_NFKB2_NFKBIB_REL_IKBKG__NFKB1_NFKBIE_RELB__NFKBIA_RELA_TNIP2
0.01817 0.00717 0.02857BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.11070 0.03285 0.16703CORUM_CHROMOSOMAL_PASSENGER_COMPLEX_CPC_INCENP_CDCA8_BIRC5_AURKB
0.00000 0.00000 0.14155LEE_LIVER_CANCER_E2F1_UP
0.00000 0.00000 0.00031FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00240 0.00255 0.09544LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
0.00000 0.00000 0.00642GAURNIER_PSMD4_TARGETS
0.00010 0.00070 0.00462GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.04059 0.11655 0.09797NETPATH_TNF_ALPHA_PATHWAY_UP
0.00269 0.00012 0.02743ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00047 0.00032 0.04550GESERICK_TERT_TARGETS_DN
0.04018 0.00009 0.00478AMIT_SERUM_RESPONSE_120_MCF10A
0.09965 0.00506 0.01394BERENJENO_TRANSFORMED_BY_RHOA_UP
0.00000 0.00000 0.14130LEE_LIVER_CANCER_MYC_E2F1_UP
0.00000 0.00005 0.18897REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.17152 0.01412 0.04719SESTO_RESPONSE_TO_UV_C3
0.00000 0.00000 0.01897VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.02731 0.01485 0.09794REACTOME_DEATH_RECEPTOR_SIGNALLING
0.08881 0.00260 0.13545LY_AGING_MIDDLE_DN
0.00175 0.00022 0.09792GEISS_RESPONSE_TO_DSRNA_UP
0.02816 0.16870 0.09823NCI_ANTHRAXPATHWAY
0.00221 0.00050 0.13111SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.17318 0.07563 0.10953CORUM_LCK-SLP76-PLC-GAMMA-1-LAT_COMPLEX_PERVANADATE-ACTIVATED
0.09979 0.02576 0.00643ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.00053 0.00000 0.07292ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.01722 0.01107 0.17825REACTOME_GPCR_LIGAND_BINDING
0.00003 0.00000 0.00659TIAN_TNF_SIGNALING_VIA_NFKB
0.00000 0.00000 0.08881GAL_LEUKEMIC_STEM_CELL_DN
0.00212 0.00020 0.05051HUMMEL_BURKITTS_LYMPHOMA_DN
0.00053 0.00083 0.10116ZHU_CMV_ALL_UP
0.01775 0.06977 0.07780KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.16268 0.15053 0.19376OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.00021 0.00011 0.04602LEE_LIVER_CANCER_HEPATOBLAST
0.00040 0.00000 0.04193NAGASHIMA_EGF_SIGNALING_UP
0.00153 0.00184 0.02655KEGG_TYPE_I_DIABETES_MELLITUS
0.17339 0.00594 0.15834BENPORATH_PROLIFERATION
0.02646 0.00070 0.02006AMIT_EGF_RESPONSE_60_MCF10A
0.00358 0.00151 0.15037HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00000 0.00000 0.10177KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.00123 0.00006 0.05845MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.00488 0.00301 0.00628OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.18032 0.00101 0.11016WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.03342 0.02416 0.13487RHODES_UNDIFFERENTIATED_CANCER
0.19909 0.08549 0.17704CORUM_CHROMOSOMAL_PASSENGER_COMPLEX_CPC_CDCA8_AURKB_BIRC5
0.06161 0.00288 0.04170KEGG_ASTHMA
0.00697 0.01045 0.05167AUJLA_IL22_AND_IL17A_SIGNALING
0.00000 0.00000 0.07941CROONQUIST_STROMAL_STIMULATION_UP
0.00006 0.00000 0.19382LEE_LIVER_CANCER_MYC_TGFA_UP
0.01150 0.00166 0.19091WU_CELL_MIGRATION
0.00000 0.00000 0.13823KHETCHOUMIAN_TRIM24_TARGETS_UP
0.01387 0.02081 0.09407NCI_CMYB_PATHWAY
0.02983 0.00053 0.15757TSAI_RESPONSE_TO_RADIATION_THERAPY
0.14474 0.11413 0.04158BIOCARTA_SODD_PATHWAY
0.00000 0.00000 0.06677TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.01307 0.01959 0.02838BUDHU_LIVER_CANCER_METASTASIS_DN
0.02531 0.00015 0.02966NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00160 0.00025 0.04905HARRIS_HYPOXIA
0.00030 0.00214 0.03901DER_IFN_BETA_RESPONSE_UP
0.18332 0.02072 0.19216GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.01151 0.00714 0.03691SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.11742 0.02315 0.19344RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.00000 0.00000 0.04270BASSO_CD40_SIGNALING_UP
0.06071 0.19700 0.19494KEGG_OLFACTORY_TRANSDUCTION
0.00003 0.00027 0.00824SOUCEK_MYC_TARGETS
0.00161 0.00004 0.01700MARZEC_IL2_SIGNALING_UP
0.00648 0.00000 0.13564NAGASHIMA_NRG1_SIGNALING_UP
0.00871 0.00448 0.16123BIOCARTA_BLYMPHOCYTE_PATHWAY
0.17707 0.01086 0.18025TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.00034 0.00005 0.10240BILBAN_B_CLL_LPL_DN
0.00029 0.00001 0.15514MAHADEVAN_RESPONSE_TO_MP470_UP
0.00000 0.00000 0.03198GOLDRATH_ANTIGEN_RESPONSE
0.01590 0.00829 0.09531BIOCARTA_TID_PATHWAY
0.00696 0.00024 0.15734BILD_HRAS_ONCOGENIC_SIGNATURE
0.12888 0.01100 0.13575AMUNDSON_GAMMA_RADIATION_RESISTANCE
0.00001 0.00000 0.18585LIANG_SILENCED_BY_METHYLATION_2
0.01097 0.00307 0.00563DAUER_STAT3_TARGETS_UP
0.07943 0.02560 0.08990KEGG_VIRAL_MYOCARDITIS
0.05787 0.02449 0.07231CHIN_BREAST_CANCER_COPY_NUMBER_UP
0.06898 0.00466 0.18787ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.00000 0.00000 0.01414KEGG_LEISHMANIA_INFECTION
0.00000 0.00122 0.18592DER_IFN_ALPHA_RESPONSE_UP
0.02293 0.11208 0.08096WU_HBX_TARGETS_1_UP
0.05909 0.00102 0.04947AMIT_EGF_RESPONSE_60_HELA
0.06022 0.00632 0.01578MARKS_HDAC_TARGETS_DN
0.01709 0.00291 0.08869CHEN_HOXA5_TARGETS_9HR_UP
0.03944 0.00111 0.06885DAZARD_UV_RESPONSE_CLUSTER_G2
0.08348 0.00163 0.18357NCI_CD40_PATHWAY
0.00000 0.00000 0.01946MCLACHLAN_DENTAL_CARIES_DN
0.06393 0.03286 0.02108LEI_MYB_TARGETS
0.00009 0.00014 0.09553KEGG_ALLOGRAFT_REJECTION
0.18314 0.04027 0.02216LEE_LIVER_CANCER_SURVIVAL_DN
0.00705 0.00005 0.19786AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.00000 0.00010SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00007 0.00003 0.02218GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00000 0.00000 0.00017ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.01254 0.01244 0.06487BIOCARTA_HSP27_PATHWAY
0.03251 0.02732 0.07093BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.03146 0.00595 0.03484BIOCARTA_INFLAM_PATHWAY
0.00000 0.00000 0.00362SANA_TNF_SIGNALING_UP
0.00000 0.00000 0.10219MOSERLE_IFNA_RESPONSE
0.11435 0.00276 0.12919FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.15854 0.01080 0.17504SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00000 0.00000 0.09817FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.03422 0.02073 0.16370REACTOME_PECAM1_INTERACTIONS
0.17108 0.08885 0.15100EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.00262 0.00004 0.00468HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.04910 0.01027 0.12126GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.00029 0.00974 0.08894SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.13365 0.00017 0.10192KIM_WT1_TARGETS_UP
0.02300 0.00161 0.05160PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.08574 0.00241 0.10384FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.01044 0.00252 0.05929KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.00040 0.00000 0.08873CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.02814 0.00336 0.05866UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.01646 0.00063 0.05877XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.12303 0.05653 0.09826BIOCARTA_KERATINOCYTE_PATHWAY
0.00024 0.00012 0.00520BIOCARTA_GRANULOCYTES_PATHWAY
0.01168 0.00140 0.11092CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.00000 0.00000 0.14126HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.01014 0.01174 0.06683NETPATH_T_CELL_RECEPTOR_PATHWAY_UP
0.00087 0.00000 0.14119CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.00001 0.00009 0.00050GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.05925 0.06016 0.14149GOUYER_TATI_TARGETS_UP
0.00511 0.00265 0.00613OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00000 0.00001 0.08892BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.00069 0.00288 0.19032MATSUDA_NATURAL_KILLER_DIFFERENTIATION